FIELD: medicine.
SUBSTANCE: invention relates to chemotherapy. Disclosed is method of treating cancer, other than melanoma, consisting in cancer cell apoptosis. Method involves administering a therapeutically effective amount of dexanabinol or its salt or solvate, where cancer represents one or more of following: liver cancer, oesophageal cancer, pancreatic cancer, small cell lung cancer and gastric carcinoma.
EFFECT: technical result consists in cancer cell apoptosis and in their lower resistance to dexanabinol compared to currently used chemotherapeutic agents.
11 cl, 3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ONCOLYTIC VIRAL VECTORS AND USE THEREOF | 2017 |
|
RU2749050C2 |
| CANCER TREATMENT WITH TG02 | 2017 |
|
RU2749025C2 |
| METHOD OF TREATING CANCER (VERSIONS) | 2006 |
|
RU2447889C2 |
| ANTICANCER COMPOSITION CONTAINING A RECOMBINANT ADENOVIRUS EXPRESSING A DESTRUCTIVE FACTOR FOR AN EXTRACELLULAR MATRIX | 2017 |
|
RU2742726C2 |
| COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID | 2011 |
|
RU2605335C2 |
| COMBINATION THERAPY WITH ANTICANCER ALKALOID | 2018 |
|
RU2767664C2 |
| COMBINATION THERAPY WITH ANTITUMOR ALKALOID | 2011 |
|
RU2743643C2 |
| COMBINED IMMUNOTHERAPEUTIC APPROACH TO CANCER TREATMENT | 2015 |
|
RU2716821C2 |
| COMBINATION THERAPY WITH ANTITUMOR ALKALOID | 2018 |
|
RU2757373C2 |
| PROCASPASE 3 ACTIVATION BY COMBINATION THERAPY | 2013 |
|
RU2659936C2 |
